Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Consolidated Net Profit

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹260 Cr₹300 Cr₹164 Cr₹64 Cr₹81 Cr

What is the latest Consolidated Net Profit of NEULAND LABORATORIES ?

The latest Consolidated Net Profit ratio of NEULAND LABORATORIES is ₹260 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹260 Cr
Mar2024₹300 Cr
Mar2023₹164 Cr
Mar2022₹64 Cr
Mar2021₹81 Cr

How is Consolidated Net Profit of NEULAND LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹260 Cr
-13.32
Mar2024 ₹300 Cr
83.51
Mar2023 ₹164 Cr
156.21
Mar2022 ₹64 Cr
-20.85
Mar2021 ₹81 Cr -

Compare Consolidated Net Profit of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹17,109.4 Cr -1.8% 4.4% 23.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 0.4% 5.6% 1.8% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr -0.5% 3.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.5% 10% 41.5% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 1.5% 4.8% 9.1% Stock Analytics
CIPLA ₹108,703.0 Cr -1.7% 1% -10.5% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-1.8%

4.4%

23.8%

SENSEX

-1.5%

0.8%

8.2%


You may also like the below Video Courses